Otometrics Launches Aurical® IQ – Delivering the First and Only Guided Workflow Enabling up to 51% Faster Fittings and 39% Improved Workflow Accuracy
14.10.2026 09:00:00 CEST | Business Wire | Press Release
Otometrics, the Hearing & Balance division of Natus Sensory, today announced Aurical® IQ, the next generation of its trusted hearing aid fitting and verification platform. Combining the first and only Guided Workflow for hearing aid fitting and verification, support for the NAL-NL3 Fitting System and a redesigned Otosuite® software experience, Aurical IQ is designed to help hearing care professionals work more efficiently and follow best-practice fitting procedures with greater consistency.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014023398/en/
Aurical IQ
Guided Workflow provides structured, step-by-step guidance through the fitting and verification process, designed to make best-practice fitting easier to follow.
A new chapter of innovation for Otometrics
Clinical evaluations demonstrated measurable benefits for clinicians at different levels of experience. Experienced clinicians achieved up to 51% faster fitting times using Guided Workflow compared with Aurical’s classic workflow.* For newer clinicians, Guided Workflow improved workflow accuracy by 39%.**
“Aurical IQ represents a new chapter of innovation for Otometrics,” said Peter Reimer, CEO, Natus Sensory. “We are building on decades of trusted hearing care expertise with solutions that address the real needs of clinicians today while preparing for what comes next. Aurical IQ is part of a broader wave of innovation across Otometrics, reflecting the renewed momentum in the business and our commitment to delivering meaningful innovation for hearing care professionals.”
For Otometrics, Aurical IQ is about bringing meaningful innovation into everyday clinical practice,” said Carsten Kind, Business Unit Leader, Otometrics, Natus Sensory. “It is also an important first step in how we want to move the business forward: with focused innovation that is practical, clinically relevant and built around how hearing care professionals work. We are building on a trusted Aurical platform, while creating a stronger foundation for future automation and AI-enabled capabilities.
Bringing NAL-NL3 into the fitting workflow
Aurical IQ also supports the NAL-NL3 Fitting System, the latest generation of the National Acoustic Laboratories’ hearing aid prescription system.
NAL-NL3 builds on decades of NAL research and introduces new capabilities designed to support contemporary hearing aid fitting, including the core NAL-NL3 Prescription and Modules addressing specific fitting requirements.
“NAL is pleased to see the NAL-NL3 Fitting System, with the core Prescription and Modules for special use cases, integrated into the latest release from Otometrics,” said Brent Edwards, Managing Director, National Acoustic Laboratories. “We are proud to collaborate with fellow innovative technology leaders such as Otometrics to bring impactful technologies to hearing care professionals, enabling improved care and better outcomes for people with hearing difficulties.”
Ready for tomorrow
Aurical IQ brings together the trusted fitting and verification capabilities of Aurical with a redesigned software experience and a platform created to support continued innovation.
Alongside Guided Workflow and NAL-NL3, Aurical IQ provides real-ear verification, binaural and wireless REM capabilities, refreshed Aurical hardware and longer probe leads designed to provide greater flexibility in complex fitting situations. Its re-engineered software foundation is designed to evolve as clinical workflows, fitting standards and connectivity develop, creating a foundation for further automation and future AI-powered capabilities.
Aurical IQ will be officially introduced at EUHA 2026 in Hanover, Germany, where hearing care professionals can experience Guided Workflow and the new Aurical IQ platform firsthand at the Otometrics booth, #514.
About Otometrics
Meaningful moments in life begin with a sense – a sound, a movement, a connection to the world around us. That belief guides everything we do at Otometrics.
Otometrics is the Hearing & Balance division of Natus Sensory, supporting clinicians worldwide with trusted solutions for hearing assessment, hearing aid fitting and verification, tympanometry, balance assessment and digital ear scanning. Our portfolio includes Aurical®, Madsen®, Otoscan®, ICS® and Bio-logic®, supporting hearing and balance professionals across the patient journey.
Built on decades of hearing and balance expertise, we develop intuitive, reliable solutions grounded in real-world clinical needs – helping clinicians work with greater confidence and efficiency today while advancing the future of hearing and balance care.
Natus Sensory is an ARCHIMED company since 2022. Learn more on our website Home - Natus Sensory.
About ARCHIMED
With offices in Europe, North America and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Animal & Environmental Health, Biopharma Products, Consumer Health, Diagnostics, Healthcare IT, Life Science Tools & Services, and MedTech. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages $15 billion across its various funds. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation. ARCHIMED - Impacting Healthcare
* In an experienced clinician workflow comparison study, users demonstrated up to 51% faster fitting times with Guided Workflow compared with the Classic Workflow.
** In a newer clinician onboarding evaluation study, the Guided Workflow improved workflow accuracy by reducing errors by 39%
View source version on businesswire.com: https://www.businesswire.com/news/home/20261014023398/en/
Contacts
Media Contact:
Catherine Conlon
Catherine.conlon@natus.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CORRECTING and REPLACING Yamaha to Acquire Disguise, Expanding Its Capabilities in Integrated Audio, Video, Lighting and Media13.11.2026 18:10:00 CET | Press Release
Please replace the release issued Nov. 12, 2026, at 11:00 p.m. PT/Nov. 13, 2026, at 2:00 a.m. ET with the following corrected version due to multiple revisions in the third paragraph. This release has been updated to ensure the accuracy of certain references in the original version. The updated release reads: YAMAHA TO ACQUIRE DISGUISE, EXPANDING ITS CAPABILITIES IN INTEGRATED AUDIO, VIDEO, LIGHTING AND MEDIA Acquisition combines Yamaha’s audio expertise with Disguise’s software and media server technologies Yamaha Corporation today announced an agreement to acquire Disguise Technologies Limited (“Disguise”), a London-based provider of software and media server technologies for live and immersive experiences. Yamaha will acquire the company by purchasing all shares in its parent, Butterfly Topco Limited. The acquisition will expand Yamaha’s capabilities beyond audio into integrated audio, video, lighting and media solutions, in line with its strategy to expand beyond hardware into soft
VELOCIFERO Takes Action Against Counterfeiting in China13.11.2026 17:32:00 CET | Press Release
VELOCIFERO is taking action against counterfeiting in China. White s.r.o., the exclusive owner of the VELOCIFERO brand and its related intellectual property rights, has launched decisive measures to protect its creative and industrial assets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261113797570/en/ Photo courtesy of White s.r.o. “Vehicle sealed in Chongqing as part of actions undertaken to protect VELOCIFERO’s intellectual property rights.” The matter originated in June 2026 when, according to the company’s complaint, computers were removed from the technical office of Taizhou Siweiluo, the company appointed to manufacture VELOCIFERO products. White s.r.o. subsequently became aware of the promotion and sale of vehicles that it believes were produced in violation of its intellectual property rights. White s.r.o. therefore decided to take direct action in China, entrusting the protection of its rights to Shanghai-based
LangChain Raises $300M to Enable Every Company to Own Their Intelligence13.11.2026 16:53:00 CET | Press Release
LangChain today announced it has raised $300 million in new funding at a $3 billion valuation, bringing total funding to date to $460 million. The round was led by existing investor CapitalG, with significant participation from new investors GIC and DFJ Growth and existing investors IVP and Sapphire Ventures. LangChain is advancing its mission to help every company own its intelligence. As agents transform the economy, companies are building domain-specific agents differentiated by their knowledge, data, and user experience. These agents will power new products and transform internal company operations, creating lasting competitive advantages for the companies that control them. "Agents are going to transform how companies operate and the products they deliver. The companies that control these systems will build lasting competitive advantages," said Harrison Chase, Co-Founder and CEO of LangChain. "Every company should be free to choose the best models for its needs, control its data a
Kinaxis Named a Leader in Five 2026 IDC MarketScapes for Worldwide Supply Chain Planning13.11.2026 13:00:00 CET | Press Release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced it has been named a Leader in five 2026 IDC MarketScape vendor assessments for worldwide supply chain planning. The recognition spans the overall market and four industries - discrete industries, process industries, consumer packaged goods and life sciences industries - all served by a single platform, Kinaxis Maestro®, the company's AI-powered supply chain orchestration platform. "Supply chain leaders don't need a better forecast once a month. They need to know what changed this morning, what it means across the business, and what to do about it," said Andrew Bell, Chief Product Officer of Kinaxis. "I believe being named a Leader across five IDC MarketScape vendor assessments, in industries that plan in very different ways, shows that a single concurrent platform is the right foundation for that. Operational orchestration builds on it by connecting planning, decisions and ex
SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results13.11.2026 12:30:00 CET | Press Release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields to medical institutions in Japan and abroad, today announced its consolidated financial results for the third quarter of fiscal year 2026 (the three months ended September 30, 2026) and the three cumulative quarters of fiscal year 2026 (the nine months ended September 30, 2026). Third Quarter 2026 Financial Highlights Total revenues were $59 million, up 35% year-over-year. Income from operations was $26 million, up 66% year-over-year, with an operating margin of 45%. Net income attributable to SBC Medical was $16 million, up 22% year-over-year. Net income margin was 27%, a decrease of 3 percentage points year-over-year. Adjusted EBITDA1 was $28 million, up 66% year-over-year. Adjusted EBITDA margin1 expanded 9 percentage points year-over-year to 47%. Basic earnings per share (EPS) was $0.15, u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom